Tetrahydro-6-undecyl-2H-pyran-2-one
Common Name: |
Tetrahydro-6-undecyl-2H-pyran-2-one |
IUPAC Name: |
6-undecyloxan-2-one |
Molecular Formula: |
C16H30O2 |
SMILES: |
CCCCCCCCCCCC1CCCC(=O)O1 |
Inchi: |
1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-12-15-13-11-14-16(17)18-15/h15H,2-14H2,1H3 |
Inchi Key: |
ZMJKQSSFLIFELJ-UHFFFAOYSA-N |
Cas No: |
7370-44-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
254.41 |
Mass (g/mol) |
254.225 |
Molar Refractivity |
78.20 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
10 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
38.00 |
Boiling Point (°C@760.00mm Hg) |
349.00 to 350.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000046 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.94 |
LogP |
5.003 |
iLOGP |
3.92 |
XLOGP3 |
5.79 |
WLOGP |
5.00 |
MLOGP |
3.80 |
ESOL Log S |
-4.41 |
ESOL Solubility (mg/ml) |
0.01 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-6.11 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-5.11 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.74 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.713 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.69 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |